eCHANGE: Evaluating Community Health Centers' Adoption of a New Global Capitation Payment

Sponsor
Oregon Health and Science University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02637869
Collaborator
OCHIN, Inc. (Other), Robert Wood Johnson Foundation (Other), Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
400,000
58

Study Details

Study Description

Brief Summary

The investigators are conducting a prospective analysis of the Alternative Payment Methodology (APM) demonstration project sites. The investigators' goal is to conduct a cross project analysis of findings. The investigators propose to use mixed methods to study processes and outcomes associated with the APM natural experiment in payment reform. The investigators hypothesize that Community Health Centers (CHCs) participating in the APM demonstration project will redesign their workflows to better focus on patient and population health needs, resulting in reallocation of financial resources, lower overall costs, changes in utilization patterns, and improved quality.

Condition or Disease Intervention/Treatment Phase
  • Other: Alternative Payment Model

Detailed Description

Led by the Oregon Primary Care Association, three community health center (CHC) organizations in Oregon developed an Alternative Payment Methodology (APM). Under this APM pilot participating CHCs will receive a prospective payment system (PPS) payment as a capitated equivalent in a per-member-per-month rate for all of their Medicaid patients. Oregon CHC organizations (several clinic sites) implemented Phase I of this demonstration project on March 1, 2013; Phase II A was implemented on July 1, 2014; Phase II B on October 1, 2014; and Phase III began July 1, 2015.

We are a prospective analysis of the APM project sites. We propose to use mixed methods to study processes and outcomes associated with the APM natural experiment in payment reform. We hypothesize that CHCs participating in the APM demonstration project will redesign their workflows to better focus on patient and population health needs, resulting in reallocation of financial resources, lower overall costs, changes in utilization patterns, and improved quality.

The study will include baseline qualitative data collection as clinics are transitioning to the APM methodology. We will conduct 2 site visits to each intervention clinic to observe practice changes that occurred post APM-implementation (first visit approximately 12-18 months post-APM implementation; second visit approximately 30-36 months post-APM implementation). We will also assemble and analyze of pre-post quantitative and qualitative datasets, and interpretation and dissemination of study findings.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400000 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Evaluating Community Health Centers' Adoption of a New Global Capitation Payment
Study Start Date :
Jul 1, 2015
Anticipated Primary Completion Date :
May 1, 2020
Anticipated Study Completion Date :
May 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Control Group - non-intervention

Clinics that did not participate in the APM project

Alternative Payment Model -intervention

Oregon developed an Alternative Payment Methodology (APM). Under this APM pilot participating CHCs will receive a prospective payment system (PPS) payment as a capitated equivalent in a per-member-per-month rate for all of their Medicaid patients

Other: Alternative Payment Model
Oregon developed an Alternative Payment Methodology (APM). Under this APM pilot participating CHCs will receive a prospective payment system (PPS) payment as a capitated equivalent in a per-member-per-month rate for all of their Medicaid patients

Outcome Measures

Primary Outcome Measures

  1. Internal services utilization [≤3 years pre-APM implementation and ≤3 years post]

    Number and type of internal services utilized including number and ratio of "traditional" face to face visits vs. "nontraditional" encounters and communication via phone, personal health record, and email

Secondary Outcome Measures

  1. Quality care measures [≤3 years pre-APM implementation and ≤3 years post]

    We selected measures that are: 1) identified by Oregon's Medicaid program and/or those on the list of Clinical Quality Measures in the electronic health record (EHR) incentive programs; 2) feasibly measured with EHR or Medicaid claims data; 3) representative across age groups and gender; 4) representative of treatment levels (e.g., prevention, acute and chronic condition care); and 5) relevant to CHC populations.

  2. External services utilization [≤3 years pre-APM implementation and ≤3 years post]

    Number and type of external services utilized including percent of patients with a follow-up appointment after discharge and average wait time

  3. Medicaid expenditures [≤3 years pre-APM implementation and ≤3 years post]

    We will calculate the average pre-post APM difference in total Medicaid expenditures attributable to the subpopulation of Medicaid-insured patients in APM intervention clinics, subtracted by the average difference among Medicaid-insured patients in comparison clinics

Other Outcome Measures

  1. Study the change processes associated with APM implementation [≤3 years pre-APM implementation and ≤3 years post]

    Qualitative assessment of practice change through interviews and site visits

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Total clinic population:

established patients at intervention and control clinics aged 2-64

  1. Medicaid Population:

Medicaid-enrolled patients at intervention and control clinics aged 2-64

Exclusion Criteria:
  1. Total clinic population:

non-established patients at intervention and control clinics aged 2-64

  1. Medicaid Population:

non-Medicaid-enrolled patients at intervention and control clinics aged 2-64

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Oregon Health and Science University
  • OCHIN, Inc.
  • Robert Wood Johnson Foundation
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: John Heintzman, MD, MPH, Oregon Health and Science University
  • Study Director: Heather Angier, MPH, Oregon Health and Science University

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
John Heintzman, Principal Investigator, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT02637869
Other Study ID Numbers:
  • AHRQ R01HS22651
  • 71125
First Posted:
Dec 22, 2015
Last Update Posted:
Oct 14, 2019
Last Verified:
Oct 1, 2019
Keywords provided by John Heintzman, Principal Investigator, Oregon Health and Science University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2019